Abstract
The oral delivery of genistein (GEN) is hindered by its low bioavailability. The delivery of tetramethylpyrazine (TMP or ligustrazine) is faced with physical instability challenges due to its high sublimation tendency. We tackled respective challenges of the two drugs by forming a cocrystal. The GEN-TMP cocrystal exhibits a significantly reduced sublimation tendency than TMP and a significant enhancement in both the in vitro release rate and bioavailability in rats than GEN. Thus, cocrystallization simultaneously improves pharmaceutical properties of both parent drugs.
Original language | English (US) |
---|---|
Pages (from-to) | 3461-3468 |
Number of pages | 8 |
Journal | Crystal Growth and Design |
Volume | 21 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2 2021 |
Bibliographical note
Funding Information:This work was supported by grants from the National Natural Science Foundation of China (Nos. 31872508 and 32002326) and Key Research grants of Hebei (19227505D). We acknowledge the Minnesota Supercomputing Institute at the University of Minnesota for providing resources that contributed to the research results reported within this manuscript. URL: http://www.msi.umn.edu
Publisher Copyright:
© 2021 American Chemical Society